前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202102235187926040
整理番号：21A0021198
結腸直腸癌におけるNOP58動員を介した小核小体RNA仲介2→γ-O-メチル化を促進する長鎖非コードRNA ZFAS1【JST・京大機械翻訳】
Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2′-O-methylation via NOP58 recruitment in colorectal cancer
Wu Huizhe
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Wu Huizhe
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Qin Wenyan
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Qin Wenyan
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Lu Senxu
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Lu Senxu
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Wang Xiufang
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Wang Xiufang
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Zhang Jing
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Zhang Jing
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Sun Tong
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Sun Tong
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Hu Xiaoyun
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Hu Xiaoyun
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Li Yalun
(Department of Anorectal Surgery, First Hospital of China Medical University, Shenyang, People’s Republic of China)
,
Chen Qiuchen
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Chen Qiuchen
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Wang Yuanhe
(Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, People’s Republic of China)
,
Zhao Haishan
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Zhao Haishan
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Piao Haiyan
(Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, People’s Republic of China)
,
Zhang Rui
(Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, People’s Republic of China)
,
Wei Minjie
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Wei Minjie
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
資料名：
Molecular Cancer (Web)
(Molecular Cancer (Web))
巻： 19 号： 1 ページ： 1-22 発行年： 2020年
JST資料番号： U7336A ISSN： 1476-4598 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： イギリス (GBR) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。